This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Editorial Comment to Activity of axitinib in patients with metastatic renal cell carcinoma previously treated with both vascular endothelial growth factor receptor tyrosine‐kinase inhibitor and mammalian target of rapamycin inhibitor. (24th April 2014)
Record Type:
Journal Article
Title:
Editorial Comment to Activity of axitinib in patients with metastatic renal cell carcinoma previously treated with both vascular endothelial growth factor receptor tyrosine‐kinase inhibitor and mammalian target of rapamycin inhibitor. (24th April 2014)
Main Title:
Editorial Comment to Activity of axitinib in patients with metastatic renal cell carcinoma previously treated with both vascular endothelial growth factor receptor tyrosine‐kinase inhibitor and mammalian target of rapamycin inhibitor